vs
Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
CBAK Energy Technology, Inc. is the larger business by last-quarter revenue ($58.8M vs $47.7M, roughly 1.2× IRONWOOD PHARMACEUTICALS INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -12.5%, a 7.8% gap on every dollar of revenue. On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $16.1M). Over the past eight quarters, CBAK Energy Technology, Inc.'s revenue compounded faster (-0.0% CAGR vs -20.2%).
CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
CBAT vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.8M | $47.7M |
| Net Profit | $-7.4M | $-2.3M |
| Gross Margin | 7.3% | — |
| Operating Margin | -13.6% | 14.3% |
| Net Margin | -12.5% | -4.8% |
| Revenue YoY | 131.8% | -47.3% |
| Net Profit YoY | -63.6% | -200.9% |
| EPS (diluted) | $-0.08 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.8M | $47.7M | ||
| Q3 25 | $60.9M | $122.1M | ||
| Q2 25 | $40.5M | $85.2M | ||
| Q1 25 | $34.9M | $41.1M | ||
| Q4 24 | $25.4M | $90.5M | ||
| Q3 24 | $44.6M | $91.6M | ||
| Q2 24 | $47.8M | $94.4M | ||
| Q1 24 | $58.8M | $74.9M |
| Q4 25 | $-7.4M | $-2.3M | ||
| Q3 25 | $2.7M | $40.1M | ||
| Q2 25 | $-3.1M | $23.6M | ||
| Q1 25 | $-1.6M | $-37.4M | ||
| Q4 24 | $-4.5M | $2.3M | ||
| Q3 24 | $17.6K | $3.6M | ||
| Q2 24 | $6.4M | $-860.0K | ||
| Q1 24 | $9.8M | $-4.2M |
| Q4 25 | 7.3% | — | ||
| Q3 25 | 8.0% | — | ||
| Q2 25 | 11.0% | — | ||
| Q1 25 | 13.7% | — | ||
| Q4 24 | 13.1% | — | ||
| Q3 24 | 15.6% | — | ||
| Q2 24 | 26.6% | — | ||
| Q1 24 | 31.9% | — |
| Q4 25 | -13.6% | 14.3% | ||
| Q3 25 | -6.6% | 61.8% | ||
| Q2 25 | -8.7% | 53.2% | ||
| Q1 25 | -8.2% | -70.7% | ||
| Q4 24 | -26.0% | 34.8% | ||
| Q3 24 | -1.9% | 28.0% | ||
| Q2 24 | 12.4% | 26.5% | ||
| Q1 24 | 17.4% | 14.7% |
| Q4 25 | -12.5% | -4.8% | ||
| Q3 25 | 4.4% | 32.8% | ||
| Q2 25 | -7.6% | 27.7% | ||
| Q1 25 | -4.5% | -90.9% | ||
| Q4 24 | -17.8% | 2.5% | ||
| Q3 24 | 0.0% | 4.0% | ||
| Q2 24 | 13.5% | -0.9% | ||
| Q1 24 | 16.7% | -5.6% |
| Q4 25 | $-0.08 | $0.01 | ||
| Q3 25 | $0.03 | $0.23 | ||
| Q2 25 | $-0.03 | $0.14 | ||
| Q1 25 | $-0.02 | $-0.23 | ||
| Q4 24 | $-0.05 | $0.03 | ||
| Q3 24 | $0.00 | $0.02 | ||
| Q2 24 | $0.07 | $-0.01 | ||
| Q1 24 | $0.11 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.3M | $215.5M |
| Total DebtLower is stronger | $4.1M | — |
| Stockholders' EquityBook value | $112.7M | $-261.8M |
| Total Assets | $426.2M | $396.9M |
| Debt / EquityLower = less leverage | 0.04× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.3M | $215.5M | ||
| Q3 25 | $10.5M | $140.4M | ||
| Q2 25 | $45.7M | $92.9M | ||
| Q1 25 | $9.6M | $108.5M | ||
| Q4 24 | $11.0M | $88.6M | ||
| Q3 24 | $24.2M | $88.2M | ||
| Q2 24 | $44.1M | $105.5M | ||
| Q1 24 | $23.8M | $121.5M |
| Q4 25 | $4.1M | — | ||
| Q3 25 | $4.8M | $199.5M | ||
| Q2 25 | $4.9M | $199.3M | ||
| Q1 25 | $4.1M | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $112.7M | $-261.8M | ||
| Q3 25 | $121.4M | $-264.2M | ||
| Q2 25 | $118.2M | $-308.2M | ||
| Q1 25 | $120.8M | $-334.1M | ||
| Q4 24 | $121.7M | $-301.3M | ||
| Q3 24 | $131.2M | $-311.3M | ||
| Q2 24 | $126.6M | $-321.7M | ||
| Q1 24 | $120.9M | $-330.5M |
| Q4 25 | $426.2M | $396.9M | ||
| Q3 25 | $363.9M | $396.1M | ||
| Q2 25 | $333.1M | $342.9M | ||
| Q1 25 | $311.5M | $327.2M | ||
| Q4 24 | $302.2M | $350.9M | ||
| Q3 24 | $293.5M | $389.5M | ||
| Q2 24 | $279.6M | $395.6M | ||
| Q1 24 | $286.5M | $438.8M |
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.8M | $74.6M |
| Free Cash FlowOCF − Capex | $16.1M | $74.6M |
| FCF MarginFCF / Revenue | 27.3% | 156.3% |
| Capex IntensityCapex / Revenue | 23.4% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $3.9M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.8M | $74.6M | ||
| Q3 25 | $14.6M | $47.6M | ||
| Q2 25 | $13.8M | $-15.1M | ||
| Q1 25 | $-9.6M | $20.0M | ||
| Q4 24 | $9.6M | $15.2M | ||
| Q3 24 | $19.7M | $9.9M | ||
| Q2 24 | $2.9M | $33.5M | ||
| Q1 24 | $7.4M | $45.0M |
| Q4 25 | $16.1M | $74.6M | ||
| Q3 25 | $6.0M | $47.6M | ||
| Q2 25 | $4.1M | $-15.1M | ||
| Q1 25 | $-22.3M | $19.9M | ||
| Q4 24 | $3.9M | — | ||
| Q3 24 | $16.5M | $9.9M | ||
| Q2 24 | $2.5M | $33.4M | ||
| Q1 24 | $-454.0K | $44.9M |
| Q4 25 | 27.3% | 156.3% | ||
| Q3 25 | 9.9% | 39.0% | ||
| Q2 25 | 10.2% | -17.7% | ||
| Q1 25 | -63.9% | 48.4% | ||
| Q4 24 | 15.5% | — | ||
| Q3 24 | 37.1% | 10.8% | ||
| Q2 24 | 5.2% | 35.4% | ||
| Q1 24 | -0.8% | 60.0% |
| Q4 25 | 23.4% | 0.0% | ||
| Q3 25 | 14.1% | 0.0% | ||
| Q2 25 | 23.8% | 0.0% | ||
| Q1 25 | 36.3% | 0.1% | ||
| Q4 24 | 22.5% | 0.0% | ||
| Q3 24 | 7.0% | 0.0% | ||
| Q2 24 | 0.9% | 0.1% | ||
| Q1 24 | 13.4% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | 5.51× | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | 1115.72× | 2.71× | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBAT
| Manufacturing Lithium Batteries | $28.0M | 48% |
| Residential Energy Supply And Uninterruptable Supplies | $17.8M | 30% |
| Light Electric Vehicles | $12.9M | 22% |
| Precursor | $108.0K | 0% |
IRWD
Segment breakdown not available.
